Dose‐dependent tumor regression during sirolimus therapy in an advanced juvenile nasopharyngeal angiofibroma case
Pediatrics International · 2024
DOI: 10.1111/ped.15807 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatrics International, 2024. Verfasst von Shin Kasai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan. Hauptthemen laut MEDLINE: Angiofibroma, Dose-Response Relationship, Drug, Nasopharyngeal Neoplasms, Sirolimus. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
- Department of Otorhinolaryngology, Head and Neck Surgery, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
ORCID-Profile: Koshi Akahane
Zitieren
APA
Kasai, S., Akahane, K., Tamai, M., Goi, K., Ishii, H., Sakurai, D., & Inukai, T. (2024). Dose‐dependent tumor regression during sirolimus therapy in an advanced juvenile nasopharyngeal angiofibroma case. Pediatrics International. https://doi.org/10.1111/ped.15807
Vancouver
Kasai S, Akahane K, Tamai M, Goi K, Ishii H, Sakurai D, et al. Dose‐dependent tumor regression during sirolimus therapy in an advanced juvenile nasopharyngeal angiofibroma case. Pediatrics International. 2024. doi:10.1111/ped.15807
BibTeX
@article{Kasai2024,
author = {Kasai, Shin and Akahane, Koshi and Tamai, Minori and Goi, Kumiko and Ishii, Hiroki and Sakurai, Daiju and Inukai, Takeshi},
title = {Dose‐dependent tumor regression during sirolimus therapy in an advanced juvenile nasopharyngeal angiofibroma case},
journal = {Pediatrics International},
year = {2024},
doi = {10.1111/ped.15807}
}
EUVIMED